Response of secondary amyloidosis in psoriasis to treatment with etretinate and ultraviolet light.
D000328:Adult; D000686:Amyloidosis / Q000628:therapy*; D003131:Combined Modality Therapy; D005050:Etretinate / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D011701:PUVA Therapy; D011565:Psoriasis / Q000150:complications*; D014467:Ultraviolet Therapy
D005050:Etretinate